PL2341344T3 - Sposób diagnozowania wielotorbielowatości nerek - Google Patents

Sposób diagnozowania wielotorbielowatości nerek

Info

Publication number
PL2341344T3
PL2341344T3 PL10196792T PL10196792T PL2341344T3 PL 2341344 T3 PL2341344 T3 PL 2341344T3 PL 10196792 T PL10196792 T PL 10196792T PL 10196792 T PL10196792 T PL 10196792T PL 2341344 T3 PL2341344 T3 PL 2341344T3
Authority
PL
Poland
Prior art keywords
kidney disease
polycystic kidney
diagnosing
diagnosing polycystic
pkd
Prior art date
Application number
PL10196792T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Univ Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg filed Critical Univ Freiburg
Publication of PL2341344T3 publication Critical patent/PL2341344T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Adhesive Tapes (AREA)
  • Die Bonding (AREA)
  • External Artificial Organs (AREA)
PL10196792T 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek PL2341344T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (en) 2006-01-17 2006-01-17 Method for diagnosing polycystic kidney disease
EP10196792.5A EP2341344B1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease
EP07700227A EP1974210B1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
PL2341344T3 true PL2341344T3 (pl) 2014-09-30

Family

ID=35945115

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10196792T PL2341344T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek
PL07700227T PL1974210T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07700227T PL1974210T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek

Country Status (8)

Country Link
US (1) US20110229895A1 (pl)
EP (3) EP1808694A1 (pl)
AT (1) ATE493649T1 (pl)
DE (1) DE602007011566D1 (pl)
DK (2) DK1974210T3 (pl)
ES (2) ES2475540T3 (pl)
PL (2) PL2341344T3 (pl)
WO (1) WO2007082733A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008136080A (ru) * 2006-02-09 2010-03-20 Новартис АГ (CH) Антитела к секретируемому frizzled-родственному белку-4 (sfrp-4)
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
ES2526928T3 (es) 2008-04-30 2015-01-16 The Governing Council Of The University Of Toronto Uso de SFRP-3 en la evaluación de la insuficiencia cardíaca
WO2010079076A2 (de) * 2008-12-17 2010-07-15 Mosaiques Diagnostics And Therapeutics Ag Autosomal dominante polyzystische nierenerkrankung (adpkd)
CA2779905A1 (en) * 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2517020B1 (en) * 2009-12-23 2015-10-21 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
CA2806296A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
AU2011360257B2 (en) * 2011-02-24 2015-08-06 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a feline
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
CN105556305A (zh) * 2013-06-05 2016-05-04 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
RU2017106891A (ru) 2014-08-04 2018-09-06 Джензим Корпорейшн Биомаркеры поликистозной болезни почек и пути их применения
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
ES2933674T3 (es) 2015-03-13 2023-02-13 Univ Indiana Res & Tech Corp Inhibidores de PDE5 para uso en la reducción del tamaño del quiste renal y/o prevención del crecimiento del quiste renal
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
MX2018006250A (es) 2015-11-18 2018-09-05 Genzyme Corp Biomarcador de enfermedad poliquistica renal y usos del mismo.
CN117337394A (zh) * 2021-05-17 2024-01-02 豪夫迈·罗氏有限公司 sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断
CN113588942B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗原肌球蛋白1-IgG抗体的试剂盒
WO2025261741A1 (en) * 2024-06-19 2025-12-26 Albert-Ludwigs-Universitaet Freiburg Koerperschaft Des Oeffentlichen Rechts Synthetic lethality to treat autosomal dominant polycystic kidney disease (adpkd)
EP4667628A1 (en) * 2024-06-19 2025-12-24 Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts Synthetic lethality to treat autosomal dominant polycystic kidney disease (adpkd)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (en) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation A novel human gene similar to a secreted murine protein sFRP-1
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
EP1318840A2 (en) * 2000-07-19 2003-06-18 Genzyme Corporation PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
WO2004011618A2 (en) * 2002-07-29 2004-02-05 Hmgene, Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
JP2007535562A (ja) * 2004-04-29 2007-12-06 ジェンザイム・コーポレイション 多嚢胞性疾患の処置のための方法および組成物

Also Published As

Publication number Publication date
DK2341344T3 (da) 2014-06-30
DK1974210T3 (da) 2011-02-21
ATE493649T1 (de) 2011-01-15
EP1974210B1 (en) 2010-12-29
ES2475540T3 (es) 2014-07-11
ES2356481T3 (es) 2011-04-08
EP1974210A1 (en) 2008-10-01
WO2007082733A1 (en) 2007-07-26
EP2341344A1 (en) 2011-07-06
PL1974210T3 (pl) 2011-05-31
DE602007011566D1 (en) 2011-02-10
EP1808694A1 (en) 2007-07-18
EP2341344B1 (en) 2014-04-30
US20110229895A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
PL1974210T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2007019376A3 (en) Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2009038742A3 (en) Method for estimating risk of acute kidney injury
WO2007114901A3 (en) Method for diagnosing adhd and related behavioral disorders
WO2008084331A3 (en) Biomarkers for renal disorders
WO2007134028A3 (en) Biomarkers for depression and methods using the same
WO2006074430A3 (en) Biomarkers for melanoma
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
WO2009078950A3 (en) Method of determing excretion of sodium and other analytes
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
WO2007047408A3 (en) Promac signature application
WO2007061906A3 (en) Diagnostic and therapeutics for cardiovascular disorders
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
WO2011079280A3 (en) Compositions and methods for diagnosing and treating kidney disorders in a canine
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
WO2007032876A3 (en) Biomarkers associated with age-related macular degeneration
WO2007000349A3 (en) Optical imaging of rheumatoid arthritis
EP2326952A4 (en) BIOMARKERS, KITS AND METHODS FOR DIAGNOSING, MONITORING AND / OR STADIFYING ALZHEIMER'S DISEASE
WO2007106466A3 (en) Beta-2 microglobulin as a biomarker for peripheral artery disease